section name header

Diagnosis ⬇

Diagnosis-icon.jpg Differential Diagnosis

Insect (Arthropod) Bite Reactions (Sometimes Referred to as Papular Urticaria [see Discussion in Chapter 29: Bites, Stings, and Infestations])
  • Reactions to insect bites may be indistinguishable from ordinary hives.

  • Bites are generally seen on exposed areas.

  • They may have a central punctum and crust; they may also blister.

  • Individual lesions may last more than 24 hours.

Erythema Multiforme Minor (see Discussion below)
  • Lesions are targetoid.

  • Last more than 24 hours.

  • Generally nonpruritic.

Erythema Migrans (Acute Lyme Disease [see Discussion in Chapter 29: Bites, Stings, and Infestations])
  • May be indistinguishable from urticaria.

  • Lesions are usually solitary, annular, and target-like.

  • Lesions may last more than 24 hours.

  • Lesions are generally nonpruritic.

Urticarial Vasculitis

This condition is rare and is probably related to circulating immune complexes.

  • Persistent hive-like lesions last more than 24 hours.

  • Lesions may be tender rather than itchy.

  • Residual purpura or hyperpigmentation often ensues on resolution of lesions.

  • Evidence of vasculitis (e.g., purpura) is occasionally seen in the lesions.

  • The diagnosis is confirmed by skin biopsy.

  • Patients may have hypocomplementemia and an elevated erythrocyte sedimentation rate.

  • Urticarial vasculitis may be associated with collagen vascular diseases.

Management-icon.jpg Management

  • If possible, the cause of the hives should be eliminated, and tight clothing and hot baths and showers should be avoided, particularly in people who have a physical urticaria.

  • Salicylates, NSAIDs, and narcotics, which are all histamine-releasing agents, may aggravate both acute and chronic urticaria and should be avoided.

  • In 85% to 90% of patients with chronic urticaria, the origin remains unknown.

  • Anti-histamines are used to control and/or prevent hives and alleviate symptoms.

  • First-generation antihistamines are histamine receptor 1 (H1) blockers and include hydroxyzine (Atarax), diphenhydramine (Benadryl), and cyproheptadine (Periactin). These are usually sedating.

  • H1 and H2 blockers may be used in combination, such as cimetidine (Tagamet) plus hydroxyzine.

  • Nonsedating antihistamines, such as loratadine (Claritin) 10 mg, desloratadine (Clarinex) 5 mg, fexofenadine (Allegra) 60/180 mg, and cetirizine (Zyrtec) 10 mg, may be used during the day, and a more sedating H1 blocker or a tricyclic antidepressant drug, such as doxepin (Sinequan), may be tried at bedtime. Doxepin can be given at much lower doses than when it is used as an antidepressant (e.g., from 5 mg two times daily to 50 mg three times daily).

  • For problems at bedtime, a sedating antihistamine such as diphenhydramine or hydroxyzine may be added.

  • Patients with chronic urticaria often require much higher than the usual doses of antihistamines.

  • Systemic steroids are sometimes used for short periods to break the cycle of chronic urticaria; however, they are not indicated for long-term use in the treatment of chronic idiopathic urticaria.

  • Montelukast (Singulair), a leukotriene receptor antagonist used to treat asthma, has been found to be effective in some cases of CIU that are refractory to antihistamines.

  • Immunotherapies using prednisone, plasmapheresis, intravenous immunoglobulin, low-dose methotrexate, oral psoralens plus ultraviolet A treatment, oral tacrolimus, azathioprine, and cyclosporine have been used in severe, recalcitrant cases.

  • There have been some encouraging outcomes with the administration of the monoclonal antibody omalizumab (Xolair), a drug used for asthma, in the treatment of CIU.

  • If all else fails, a diary of daily foods eaten may be kept, with subsequent food elimination; however, this approach is rarely successful.

Helpful-Hint-icon.jpg Helpful Hints

  • Epinephrine, which is often administered by intramuscular or subcutaneous injection for acute urticaria, should not be used for routine cases of hives. It should be reserved for cases of acute anaphylaxis.

  • For the treatment of anaphylaxis, an EpiPen is a device that contains a spring-loaded needle that penetrates the recipient's skin, to deliver a predetermined dose of epinephrine via subcutaneous or intramuscular injection.

  • Patients with documented cold urticaria should be advised not to immerse themselves abruptly in cold water.

  • Children with chronic urticaria occasionally have an underlying autoimmune disease; thyroid antibodies are the most common positive finding.

  • Most cases of CIU resolve with or without treatment; on average: 50% are free of hives after 3 to 12 months; 20% are free of hives after 12 to 36 months, and 20% are free of hives after 36 to 60 months.

  • In some patients, hives may recur for many years.

Point-Remember-icon.jpg Points to Remember

  • Except for a physical urticaria and urticaria that is obviously associated with drugs and systemic disease, determining the cause of chronic urticaria is generally a fruitless task.

  • Most often, routine blood tests are of little or no value in determining the cause of acute or chronic urticaria.

  • Antihistamines remain the mainstay for treating chronic urticaria; a combination of these agents may be necessary for control.

  • Allergies are almost never the cause of chronic urticaria. Allergy testing is expensive and often tests that are positive for allergies have no relation to the patient's urticaria.

  • When individual wheals persist for more than 24 to 36 hours, the process is unlikely to be urticaria.

SEE PATIENT HANDOUT “Hives (Urticaria)” IN THE COMPANION eBOOK EDITION.

Other Information ⬆

Acute Urticaria !!navigator!!

Chronic Urticaria !!navigator!!

Dermatographism (“Skin Writing”) !!navigator!!

Cold Urticaria !!navigator!!

Light-Induced (Solar) Urticaria !!navigator!!

Cholinergic Urticaria !!navigator!!


Outline